Tools
Stock profile

ILLUMINA, INC. (ILMN)

ILMN · Latest close $210.01 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$210.01
As of Nov 18, 2026
Tracked funds holding
3 of 149
2026 Q2 13F filings
Opened / added
0 / 0
vs previous quarter
Trimmed / exited
5
vs previous quarter

ILLUMINA, INC. (ILMN) is held by 3 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 5 funds trimming or exiting versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $415.7M sold). 0 members of Congress reported 0 purchases vs 1 sale. Latest close $210.01 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Nov 11, 2026 · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Insiders · 90d
net $-415.7M
Congress
0 buys vs 1 sale
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Government relations · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Sessa Capital · Patient Capital Management · Century Management — 3 tracked funds hold ILMN. See all holders.

Insider and Congress activity

Insiders bought on the open market (0 purchases, $0) vs 88 sales ($415.7M). Insider trading 0 members of Congress reported buying (0 purchases vs 1 sale). Politician trading

Often held alongside

WATERS CORP /DE/ (WAT) · Avantor, Inc. (AVTR) · BIO-RAD LABORATORIES, INC. (BIO) · AGILENT TECHNOLOGIES, INC. (A) · METTLER TOLEDO INTERNATIONAL INC/ (MTD) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Sessa Capital3.29%1,118,374TRIMMED (-65.9%) Q3 filed Nov 16
Patient Capital Management1.99%345,314TRIMMED (-36.6%) Q3 filed Nov 12
Century Management1.62%43,610TRIMMED (-2.6%) Q3 filed Nov 16
Triple Frond Partners——EXITED
Samlyn Capital——EXITED

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: +10.2% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

293.6961.362024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding938 of 8,857 filers
Long-only filers among them934
Change vs 2026 Q1+104 net · 835 entered · 731 exited
Shares reported, all filers155,771,173
Reported value, all filers$27.0B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNasdaq
IndustryLaboratory Analytical Instruments (SIC 3826)
Revenue · FY2025$4.3B
Net income · FY2025$850.0M
Total assets · FY2025$6.6B
Shares outstanding151,000,000
Market cap (at latest close)$31.7B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Jul 24, 2026.

Short interest

Shares short · Oct 15, 20267,885,327
Share of shares outstanding5.22%
Days to cover2.94

Shares short at recent settlements — Jul 31, 2026: 8.1M · Aug 14, 2026: 9.5M · Aug 31, 2026: 9.7M · Sep 15, 2026: 10.6M · Sep 30, 2026: 9.5M · Oct 15, 2026: 7.9M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jul 24, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 20266
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 2026<0.1%

Fails to deliver at recent settlements — Jul 31, 2026: 10K · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 6.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jul 24, 2026.

Insider trading · Form 4

0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 88 sales by 2 insiders ($415.7M).

Source: SEC Form 4 filings. Open-market transactions only.

Recent open-market trades

DateInsiderRoleBuy / SellSharesPriceValueSource
Nov 11, 2026Meister Keith A.Sell15,215$212.97$3.2MSEC filing
Nov 11, 2026Meister Keith A.Sell1,103$214.02$236.1KSEC filing
Nov 11, 2026Meister Keith A.Sell26,950$215.48$5.8MSEC filing
Nov 11, 2026Meister Keith A.Sell5,122$216.64$1.1MSEC filing
Nov 11, 2026Meister Keith A.Sell8,613$217.65$1.9MSEC filing
Nov 11, 2026Meister Keith A.Sell23,064$218.50$5.0MSEC filing
Nov 11, 2026Meister Keith A.Sell12,305$219.55$2.7MSEC filing
Nov 11, 2026Meister Keith A.Sell4,618$220.45$1.0MSEC filing
Nov 11, 2026Meister Keith A.Sell1,843$221.09$407.5KSEC filing
Nov 10, 2026Ericksen Scott DVP, Chief Accounting OfficerSell267$217.76$58.1KSEC filing

Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Sep 4, 2026Corvex Management LPAffiliate of Director (1)150,000$32.0MSep 4, 2026SEC filing
Aug 27, 2026Corvex Management LPAffiliate of Director (1)200,000$45.0MAug 27, 2026SEC filing
Aug 25, 2026Corvex Management LPAffiliate of Director (1)300,000$67.0MAug 25, 2026SEC filing
Aug 21, 2026Corvex Management LPAffiliate of Director (1)250,000$53.3MAug 21, 2026SEC filing
Aug 20, 2026Corvex Management LPAffiliate of Director (1)355,000$72.8MAug 20, 2026SEC filing
Aug 18, 2026JAKOB WEDELOfficer1,033$199.5KAug 18, 2026SEC filing
Aug 4, 2026Corvex Management LPAffiliate of Director (1)840,000$166.5MAug 4, 2026SEC filing
Jul 30, 2026SCOTT DAVIESOfficer615$119.8KJul 30, 2026SEC filing
Jun 25, 2026SCOTT DAVIESOfficer615$107.7KJun 25, 2026SEC filing
Jun 25, 2026FRANCES ARNOLDFormer Director2,000$363.0KJun 25, 2026SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
May 14, 2026Capital World InvestorsSC 13G/A15,776,45210.3%Mar 31, 2026SEC filing
Apr 30, 2026Vanguard Capital ManagementSC 13G7,939,2135.2%Mar 31, 2026SEC filing
Mar 27, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Nov 13, 2025Capital World InvestorsSC 13G/A20,263,95013.2%Sep 30, 2025SEC filing
Aug 13, 2025Capital World InvestorsSC 13G/A16,866,77610.7%Jun 30, 2025SEC filing
May 13, 2025Capital World InvestorsSC 13G/A19,092,69512.1%Mar 31, 2025SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

0 members of Congress reported buying (0 purchases vs 1 sale).

Source: U.S. House Clerk and U.S. Senate eFD STOCK Act periodic transaction reports, as of Nov 16, 2026. Reported amounts are ranges, and reports can arrive up to 45 days after the trade.

Recent activity by member

MemberChamberPartyBuysSellsLatestAmount range
Cisneros, GilbertHouseD01Oct 27, 2026$1,001 - $15,000

Member-level activity in the current window, most recent first (House data to Nov 16, 2026, Senate to Oct 1, 2026). House reports arrive as PDFs without transaction-level rows in the current corpus, so this table shows per-member totals, not individual trades; the member page lists the underlying filings. Senate rows link the same way — the member page carries the eFD filing links.

Committee jurisdiction

Industry: Laboratory Analytical Instruments (SIC 3826). No standing committee maps to this industry under the site’s jurisdiction rule — see Methodology.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Government relations

Lobbying: 297 Lobbying Disclosure Act filings named this company as client, 1999–2026; most common issues: Health Issues (168), Trade (domestic/foreign) (57), Government Issues (51).

Federal contracts: $223.9M in obligated amounts, fiscal years 2021–2026.

Fiscal yearObligated amount
FY2021$43.1M
FY2022$41.1M
FY2023$46.1M
FY2024$35.8M
FY2025$33.9M
FY2026$24.0M

Largest awards collected

Award IDAgencyAmountStart
HHSN27100006Department of Health and Human Services$6.7MJun 1, 2017
75N95020F00002Department of Health and Human Services$6.5MSep 15, 2020
75D30121C10348Department of Health and Human Services$4.0MFeb 1, 2021
75N92021F00027Department of Health and Human Services$2.7MSep 14, 2021
75N92022F00032Department of Health and Human Services$2.1MSep 20, 2022

Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.

Screens & lenses

Financial Screens

· Piotroski — Financial health improved over the past year

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

· Top Relative Strength — Top 20% of the universe by 6-month return

Key figures

· Piotroski — F-score: 7 · Return on assets: 12.8% · Operating cash flow: $1.1B

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

· Politician BEST — appeared in 2 of the last 20 quarterly lists; latest 2024 Q1, ranked #23 of 50.

13F signal (2021 Q3 – 2026 Q1)EventsWin rateAvg returnSPYExcess
Heavy accumulation — 3+ tracked funds increased together475.0%+5.2%+7.0%-1.8%
Share count tripled (3x)1100.0%+19.7%+8.6%+11.1%
Heavy exit — 3+ tracked funds sold out together10.0%-28.9%-8.2%-20.7%

Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.

Also held by the tracked funds that hold ILMN — ranked by lift, the co-holding pattern described in Methodology: WATERS CORP /DE/ (WAT) · Avantor, Inc. (AVTR) · BIO-RAD LABORATORIES, INC. (BIO) · AGILENT TECHNOLOGIES, INC. (A) · METTLER TOLEDO INTERNATIONAL INC/ (MTD) · BRUKER CORP (BRKR) · 908 Devices Inc. (MASS) · Quanterix Corp (QTRX).

8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.

Recent 8-K filings

FiledItemsSource
Oct 29, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Oct 13, 20261.01 Entry into a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation · 9.01 Financial Statements and ExhibitsSEC filing
Aug 17, 20268.01 Other Events · 9.01 Financial Statements and ExhibitsSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

WATERS CORP /DE/ (WAT) · Track Record: how the signals scored · Practice timing on ILMN

One email a week: the week’s new filings and research. Subscribe free

← IKT  ·  IMA →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.